Gastric dumping syndrome screening: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Gastric dumping syndrome}} | {{Gastric dumping syndrome}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} | ||
==Overview== | |||
There is insufficient evidence to recommend routine screening for [disease/malignancy]. | There is insufficient evidence to recommend routine screening for [disease/malignancy]. | ||
Revision as of 15:31, 28 November 2017
|
Gastric dumping syndrome Microchapters |
|
Differentiating Gastric dumping syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Gastric dumping syndrome screening On the Web |
|
American Roentgen Ray Society Images of Gastric dumping syndrome screening |
|
Risk calculators and risk factors for Gastric dumping syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
- According to the [guideline name], screening for [disease name] is not recommended.
OR
- According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]